Africa In The News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.

Press releases published on June 10, 2026

Jun. 10, 2026

CannBro Highlights Cannabis Compliance, Medical Applications, and Supply Chain Innovation at Cannabis Expo Johannesburg 2026

Indeterminate GlobeNewswire

Jun. 10, 2026

Terra Clean Energy Corp. Files NI 43-101 Technical Report For the Marysvale Uranium Mines Project, Utah

Indeterminate GlobeNewswire

Jun. 10, 2026

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

Indeterminate GlobeNewswire

Jun. 10, 2026

Ligand Announces 2026 Investor Day in New York City

Indeterminate GlobeNewswire

Jun. 10, 2026

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease

Indeterminate GlobeNewswire

Jun. 10, 2026

Brunswick Exploration Increases Anais Strike Extent to Over 350 Meters

Indeterminate GlobeNewswire

Jun. 10, 2026

Ero Confirms High-Grade Continuity and Extends Known Mineralization at Furnas with Significant New Step-Out Intercepts

Indeterminate GlobeNewswire

Jun. 10, 2026

Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment

Indeterminate GlobeNewswire

Jun. 10, 2026

Italfarmaco annonce l’acceptation du dépôt et l’examen prioritaire par Santé Canada pour la présentation de drogue nouvelle du givinostat dans le traitement de la dystrophie musculaire de Duchenne

Indeterminate GlobeNewswire

Jun. 10, 2026

Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate

Indeterminate GlobeNewswire

Jun. 10, 2026

IUX Hits $1.5 Trillion Monthly Volume, Upgrading Infrastructure on the "Trader's Edge"

Indeterminate GlobeNewswire

Jun. 10, 2026

CONNECTA Therapeutics Initiates Phase IIa Clinical Trial of CTH120, a First-in-Class Neuroplasticity Modulator, in Fragile X Syndrome

Indeterminate GlobeNewswire

Jun. 10, 2026

Cytospire Therapeutics Appoints Samit Hirawat, M.D., as Non-Executive Director

Indeterminate GlobeNewswire

Jun. 10, 2026

Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery

Indeterminate GlobeNewswire

Jun. 10, 2026

Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering

Indeterminate GlobeNewswire

Jun. 10, 2026

Parabilis Medicines Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire